Side-by-side comparison of AI visibility scores, market position, and capabilities
AI-enabled enterprise incentive compensation management platform for complex commissions. Forrester Strong Performer in SPM Q1 2025; targets pharma, tech, and financial services with 30+ rep teams.
Performio is an incentive compensation management (ICM) platform headquartered in the United States and Australia, designed to handle enterprise-level sales teams with sophisticated commission structures. The company was recognized as a Strong Performer in The Forrester Wave for Sales Performance Management Solutions Q1 2025, reflecting its competitive capabilities in automated commission calculation, compliance, and reporting.\n\nPerformio's platform features a component-based plan builder that allows customization of preconfigured incentive types, real-time dashboards where reps see earnings and quota attainment through web portals and mobile apps (iOS and Android), and AI-enabled tools that simplify administrator workflows and accelerate strategic compensation decisions. The system automates plan acceptance, commission attribution, team payment visibility, and dispute ticketing—eliminating the operational burden that plagues spreadsheet-based commission processes.\n\nPerformio targets sales operations, finance, and RevOps teams managing 30 or more commissioned reps, with optimal fit in complex commission environments across pharmaceuticals, telecommunications, financial services, and technology. Enterprise contracts typically run $80,000–$150,000 annually for organizations with 100–250+ sales reps. The platform earns an 87% user satisfaction rating based on 1,569 reviews across major software review sites and competes with Xactly, Varicent, CaptivateIQ, and Everstage in the ICM market.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.